Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle with Xenex Germ-Zapping Robots for Room Disinfection

SAN ANTONIO, Nov. 9, 2015 /PRNewswire/ -- Surgical Site Infections (SSIs) are devastating for patients and pose a significant financial risk for hospitals. Surgical Site Infections resulting from total knee or hip procedures cause excruciating pain and suffering, have a three percent mortality rate and are associated with an additional $21,000 in additional care costs per infection. As hospitals worldwide struggle to prevent infections, Alabama-based Trinity Medical Center experienced a 100 percent decrease in Surgical Site Infection rates in its orthopedic Operating Rooms (ORs) after implementing a total joint infection control bundle that includes Xenex Germ-Zapping Robots™ to disinfect its ORs and patient rooms.

In the peer-reviewed study "Influence of a total joint infection control bundle on surgical site infection rates" in the American Journal of Infection Control (AJIC), the authors describe the measures they took to achieve a 100 percent reduction in Surgical Site Infection rates. The AJIC study states that the intervention may have prevented seven infections, averted one death, and saved $290,990 over the 12 months studied.  This is the sixth peer-reviewed study published by a hospital that experienced a decrease in Hospital Acquired Infection (HAI) rates after it began using the Xenex pulsed xenon Full Spectrum™ ultraviolet (UV) room disinfection system to destroy the microorganisms that cause HAIs.

According to the study, in 2012, Trinity's Surgical Site Infection rates were excellent; below the national average, but hospital leadership evaluated and introduced an infection control bundle in 2013 with the goal of further reducing its Surgical Site Infection rates. The bundled program that reduced total joint Surgical Site Infections at Trinity Medical Center was quality improvements and no-touch environmental disinfection with pulsed xenon UV light disinfection technology from Xenex Disinfection Services.

Trinity's Surgical Site Infection reduction results were dramatic. According to the study, in 2012, four Surgical Site Infections were reported from 200 total-hip procedures and three Surgical Site Infections were reported from 191 total-knee procedures. After implementation of the infection control bundle, no Surgical Site Infections were reported from 191 total-hip procedures or 394 total-knee procedures in 2013. During this time, antibiotic treatment and wound dressing techniques remained constant. 

Multiple studies have shown that significant environmental contamination exists in hospital rooms, even after manual cleaning has taken place. Germs and bacteria like Clostridium difficile (C.diff) and methicillin resistant Staphylococcus aureus (MRSA) can live on surfaces for months. To reduce the bacterial load in its orthopedic wing, Trinity began disinfecting its operating rooms (ORs) nightly using pulsed xenon UV disinfection. The Xenex device was operated for 5-10 minutes in multiple positions in each OR. Upon patient discharge, patient rooms were cleaned and then disinfected using the Xenex device. Compliance with the Xenex disinfection protocol was monitored using the robot's onboard data log, which communicates with a cloud-based portal where usage data is stored. The use of pulsed xenon UV disinfection was combined with quality improvement initiatives described in the paper.

Trinity Medical Center moved in October 2015 to a new facility in Birmingham, Grandview Medical Center, where they continue to use Xenex for room disinfection.

"This 100 percent reduction in infections is good news for patients in Birmingham. No one should go to the hospital for a procedure or treatment and unknowingly contract a painful and potentially lethal infection. Surgeons should want to operate at Grandview Medical Center because they are doing more to keep their patients safe by eliminating the pathogens that could endanger them," said Morris Miller, CEO of Xenex. "Trinity becomes the sixth hospital to publish a peer-reviewed outcome study showing a decrease in infection rates after using the Xenex Germ-Zapping Robot for room disinfection.  I hope that other hospitals are watching closely because Xenex offers the only UV disinfection technology shown, in multiple peer reviewed published outcome studies, to effectively reduce HAI rates."

Only UV Disinfection System Proven to Reduce HAI Rates
MD Anderson Cancer Center, the Central Texas Veterans Health Care System, Cooley Dickinson Health Care and other hospitals have published 13 studies providing evidence of the Xenex robot's efficacy in highly regarded scientific journals that include AJIC, Journal of Infection Prevention, Infection Control & Hospital Epidemiology (ICHE) and BMC Infectious Diseases. Hospitals that purchased Xenex robots have reported greater than 50 percent decreases in MRSA and C.diff infection rates in peer-reviewed literature, documenting how they used the Xenex robot in their hospital to reduce infection rates.

Designed for speed, effectiveness and ease of use, hospital cleaning staff operate the robot without disrupting hospital operations. The robot pulses intense UV light covering the entire UV spectrum, destroying viruses, bacteria and bacterial spores in a five-minute disinfection cycle. Without contact or chemicals, the robot destroys harmful microorganisms safely and effectively. The robot can disinfect 30-62 hospital rooms per day (according to Xenex customers), including: patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas. More than 300 hospitals, Veterans Affairs, Department of Defense, skilled nursing facilities, ambulatory surgery centers and long-term acute care facilities in the U.S., Europe, Canada and Africa use Xenex robots.

About Xenex Disinfection Services
Xenex's patented Full Spectrum™ pulsed xenon UV room disinfection system is used for the advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The Xenex mission is to save lives and reduce suffering by eliminating the deadly microorganisms that cause HAIs. The company is backed by well-known investors that include Malin Corporation, Battery Ventures, Targeted Technology Fund II and RK Ventures. For more information, visit www.xenex.com.

Source: http://www.prnewswire.com/news-releases/ back

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more